Peter M. Tessier

Biography

Education:  Ph.D. Chemical Engineering, University of Delaware, 2003 B.S. Chemical Engineering, University of Maine, 1998 Professional Experience: Albert M. Mattocks (Endowed) Professor of Pharmaceutical Sciences and Chemical Engineering Departments of Chemical Engineering and Pharmaceutical Sciences (equal appointments) and Biointerfaces Institute University of Michigan, Ann Arbor, MI, 2017-present Richard Baruch M.D. Career Development (Endowed) Professor  Department of Chemical & Biological Engineering Rensselaer Polytechnic Institute, Troy, NY, 2016-2017 Richard Baruch M.D. Career Development (Endowed) Associate Professor Department of Chemical & Biological Engineering Rensselaer Polytechnic Institute, Troy, NY, 2014-2016 Alexander von Humboldt Fellow Max Planck Institute of Biochemistry Martinsried, Germany, 2014-2015 Associate Professor  Department of Chemical & Biological Engineering Rensselaer Polytechnic Institute, Troy, NY, 2013-2016 Assistant Professor  Department of Chemical & Biological Engineering Rensselaer Polytechnic Institute, Troy, NY, 2007-2013 American Cancer Society Postdoctoral Fellow Whitehead Institute for Biomedical Research (MIT), Cambridge, MA, 2003-2007 Advisor: Susan Lindquist

Research Interest

The Tessier lab aims to develop next generation technologies for designing, discovering, engineering, characterizing, formulating and delivering biologics ranging from small affinity peptides to large monoclonal antibodies for molecular imaging, diagnostic and therapeutic applications. This interdisciplinary research program involves the use of experimental and computational approaches to generate new fundamental insights related to protein structure and function, molecular origins of protein-protein interactions, and sequence and structural determinants of key protein properties (stability, solubility, specificity and affinity). With an eye toward applications, the Tessier lab also develops novel high-throughput screening tools for discovering new biologics and identifying rare variants with drug-like properties for therapeutic applications.